Advertisement
CIX vs UTI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIX is a Hold and UTI is a StrongBuy.
Aroon Indicator for CIX shows an upward move is likely
CIX's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 179 similar instances where the Aroon Indicator showed a similar pattern. In 153 of the 179 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on CIX as a result. In 103 of 129 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for CIX just turned positive on November 06, 2026. Looking at past instances where CIX's MACD turned positive, the stock continued to rise in 53 of 69 cases over the following month. The odds of a continued upward trend are 77%.
CIX moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CIX crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +13.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where CIX advanced for three days, in 200 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
CIX broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. CIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.300) is normal, around the industry mean (2.996). P/E Ratio (21.742) is within average values for comparable stocks, (3.471). Projected Growth (PEG Ratio) (2.750) is also within normal values, averaging (5.749). Dividend Yield (0.031) settles around the average of (0.244) among similar stocks. P/S Ratio (2.762) is also within normal values, averaging (2.085).
UTI in upward trend: 10-day moving average moved above 50-day moving average on October 27, 2026
The 10-day moving average for UTI crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on UTI as a result. In 75 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for UTI just turned positive on November 10, 2026. Looking at past instances where UTI's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.
UTI moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +16.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTI advanced for three days, in 259 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
UTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 185 of 250 cases where UTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Bearish Trend Analysis
The 10-day RSI Indicator for UTI moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 33 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 68 cases where UTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. UTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: UTI's P/B Ratio (3.189) is slightly higher than the industry average of (1.158). UTI has a moderately high P/E Ratio (32.145) as compared to the industry average of (8.484). Projected Growth (PEG Ratio) (1.642) is also within normal values, averaging (1.327). Dividend Yield (0.004) settles around the average of (4.151) among similar stocks. P/S Ratio (1.320) is also within normal values, averaging (27.566).
CIX | UTI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 38 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 16 | 66 | |
SMR RATING 1..100 | 56 | 68 | |
PRICE GROWTH RATING 1..100 | 36 | 62 | |
P/E GROWTH RATING 1..100 | 9 | 16 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CIX's Valuation (72) in the Metal Fabrication industry is in the same range as UTI (85) in the Miscellaneous Commercial Services industry. This means that CIX’s stock grew similarly to UTI’s over the last 12 months.
CIX's Profit vs Risk Rating (16) in the Metal Fabrication industry is somewhat better than the same rating for UTI (66) in the Miscellaneous Commercial Services industry. This means that CIX’s stock grew somewhat faster than UTI’s over the last 12 months.
CIX's SMR Rating (56) in the Metal Fabrication industry is in the same range as UTI (68) in the Miscellaneous Commercial Services industry. This means that CIX’s stock grew similarly to UTI’s over the last 12 months.
CIX's Price Growth Rating (36) in the Metal Fabrication industry is in the same range as UTI (62) in the Miscellaneous Commercial Services industry. This means that CIX’s stock grew similarly to UTI’s over the last 12 months.
CIX's P/E Growth Rating (9) in the Metal Fabrication industry is in the same range as UTI (16) in the Miscellaneous Commercial Services industry. This means that CIX’s stock grew similarly to UTI’s over the last 12 months.
| CIX | UTI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 84% | 2 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 75% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 77% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 78% |
| Advances ODDS (%) | 2 days ago 75% | 2 days ago 78% |
| Declines ODDS (%) | 14 days ago 59% | 9 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 85% | 2 days ago 74% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CIX’s FA Score shows that 2 FA rating(s) are green while UTI’s FA Score has 1 green FA rating(s).
- CIX’s FA Score: 2 green, 3 red.
- UTI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CIX’s TA Score shows that 6 TA indicator(s) are bullish while UTI’s TA Score has 7 bullish TA indicator(s).
- CIX’s TA Score: 6 bullish, 4 bearish.
- UTI’s TA Score: 7 bullish, 3 bearish.
Price Growth
CIX (@Miscellaneous Commercial Services) experienced а +24.72% price change this week, while UTI (@Other Consumer Specialties) price change was +6.96% for the same time period.
The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was +0.12%. For the same industry, the average monthly price growth was -3.43%, and the average quarterly price growth was -8.01%.
The average weekly price growth across all stocks in the @Other Consumer Specialties industry was -6.64%. For the same industry, the average monthly price growth was -18.67%, and the average quarterly price growth was -26.17%.
Reported Earning Dates
UTI is expected to report earnings on Nov 18, 2026.
Industries' Descriptions
@Miscellaneous Commercial Services (+0.12% weekly)The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.
@Other Consumer Specialties (-6.64% weekly)‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.
Advertisement
CIX and
Correlation & Price change
A.I.dvisor indicates that over the last year, CIX has been loosely correlated with GHC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CIX jumps, then GHC could also see price increases.
| Ticker / NAME | Correlation To CIX | 1D Price Change % | ||
|---|---|---|---|---|
| CIX | 100% | +8.62% | ||
| GHC - CIX | 39% Loosely correlated | +0.53% | ||
| CASS - CIX | 31% Poorly correlated | +0.28% | ||
| LINC - CIX | 31% Poorly correlated | +4.55% | ||
| UTI - CIX | 31% Poorly correlated | +5.74% | ||
| AZZ - CIX | 31% Poorly correlated | -1.51% | ||
More | ||||
UTI and
Correlation & Price change
A.I.dvisor indicates that over the last year, UTI has been loosely correlated with LINC. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if UTI jumps, then LINC could also see price increases.
| Ticker / NAME | Correlation To UTI | 1D Price Change % | ||
|---|---|---|---|---|
| UTI | 100% | +5.74% | ||
| LINC - UTI | 66% Loosely correlated | +4.55% | ||
| AZZ - UTI | 49% Loosely correlated | -1.51% | ||
| APEI - UTI | 48% Loosely correlated | +2.84% | ||
| PRDO - UTI | 46% Loosely correlated | +5.21% | ||
| BV - UTI | 46% Loosely correlated | -3.54% | ||
More | ||||